INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2006

Oral ellagic acid-rich pomegranate extract inhibited UV-induced decreases in skin luminance, indicating an inhibitory effect on slight skin pigmentation.

Thirty-nine healthy female volunteers were randomly assigned to receive high-dose pomegranate extract (200 mg/d ellagic acid), low-dose (100 mg/d), or placebo for 4 weeks. Following 1.5 MED of UV irradiation on the upper arm, decreases in L values from baseline were inhibited by 1.35% (low-dose) and 1.73% (high-dose) compared to control. In stratified analyses of subjects with slight sunburn, decreases in L values were significantly inhibited compared to control at weeks 1, 2 (p<0.01), and 4 (p<0.05) in the low-dose group, and at weeks 2 and 3 (p<0.05) in the high-dose group. Questionnaires showed ameliorating tendencies for items including 'brightness of the face' and 'stains and freckles.'

Study type
Double-blind, placebo-controlled randomized trial
Who was studied
39 healthy female volunteers in their 20s to 40s (13 per group)
What was measured
Luminance (L), melanin, and erythema values after UV irradiation, and skin condition questionnaires

THE PAPER

Effects of oral administration of ellagic acid-rich pomegranate extract on ultraviolet-induced pigmentation in the human skin.

Kasai K, Yoshimura M, Koga T, Arii M, Kawasaki S. J Nutr Sci Vitaminol (Tokyo), 2006.

PubMed 17190110 ↗DOI 10.3177/jnsv.52.383 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.